A tailored course, built for your situation
Compliance-Ready AI in Pharmaceutical R&D Operations for Compliance Officers
Master the integration of AI into compliant R&D workflows with implementation-grade precision
The situation this course is for
Compliance officers are expected to validate and oversee AI-driven processes without clear frameworks or practical playbooks. Traditional training doesn’t address the technical depth or regulatory nuance required today. This gap leads to delays, rework, and misalignment between data science and QA teams.
Who this is for
A compliance, quality assurance, or regulatory affairs professional in a pharmaceutical or biotech organization who needs to govern AI-enabled R&D workflows with confidence and precision.
Who this is not for
This course is not for data scientists building models, nor for executives seeking high-level overviews. It’s specifically for compliance practitioners who must operationalize and verify AI systems within regulated environments.
What you walk away with
- Apply a structured framework to assess AI systems for compliance readiness in R&D
- Navigate GxP implications of machine learning in clinical and non-clinical data workflows
- Develop audit-ready documentation for AI model lifecycle management
- Align cross-functional teams on compliance-by-design principles for AI deployment
- Implement change control processes tailored to adaptive AI models in regulated environments
The 12 modules (with all 144 chapters)
- Defining AI in the context of drug discovery and development
- Regulatory expectations for algorithmic transparency
- Distinguishing AI from automation in lab environments
- Key differences between traditional software and adaptive models
- GxP applicability to AI-driven workflows
- Roles and responsibilities in AI governance
- Establishing a compliance baseline for AI projects
- Mapping AI use cases to risk tiers
- Understanding lifecycle phases of AI models
- Documentation expectations from regulators
- Change control implications for evolving models
- Case study: AI in preclinical data analysis
- FDA’s AI/ML action plan and implications
- EMA perspectives on AI in clinical development
- ICH updates related to data integrity and model validation
- ISO standards for AI in medical decision support
- Emerging norms from MHRA and PMDA
- Data privacy considerations in AI training sets
- Cross-border data transfer challenges
- Labeling requirements for AI-informed decisions
- Inspection trends in AI-enabled facilities
- Harmonizing compliance across jurisdictions
- Industry consortia shaping best practices
- Anticipating future regulatory shifts
- Adapting traditional CSV for adaptive systems
- Defining model performance metrics for compliance
- Establishing acceptance criteria for probabilistic outputs
- Validation of training, validation, and test datasets
- Ensuring reproducibility in model development
- Version control for models and data pipelines
- Audit trail requirements for model retraining
- Handling concept drift in production models
- Validation of third-party AI tools
- Documentation templates for model validation reports
- Role of QA in model lifecycle oversight
- Case study: validating an AI tool for toxicology prediction
- Data provenance and lineage in AI workflows
- Ensuring ALCOA+ principles in training data
- Handling missing or biased data in regulatory contexts
- Data curation standards for AI readiness
- Versioning datasets in regulated environments
- Metadata requirements for audit readiness
- Data access controls and role-based permissions
- Anonymization techniques for privacy-preserving AI
- Data retention policies for AI model artifacts
- Managing synthetic data in validation
- Cross-system data integration challenges
- Case study: data governance for AI in clinical trial enrollment
- Defining model versioning protocols
- Trigger points for revalidation
- Assessing impact of data drift on compliance
- Managing updates to training pipelines
- Documentation for model retraining events
- Approval workflows for model deployment
- Rollback strategies for failed model updates
- Audit trails for model lifecycle events
- Integration with existing change control systems
- Handling emergency model fixes
- Post-deployment monitoring requirements
- Case study: managing model updates in a GLP lab
- Common inspection findings in AI projects
- Preparing model documentation for auditors
- Demonstrating traceability from requirements to outcomes
- Responding to questions about model uncertainty
- Evidence packages for AI validation
- Training audit teams on AI concepts
- Mock inspection exercises
- Handling requests for model source code
- Proving reproducibility under inspection
- Addressing bias and fairness concerns
- Presenting model performance data clearly
- Case study: successful audit of an AI-powered QC system
- Translating technical concepts for compliance teams
- Communicating risk assessments to non-technical leaders
- Building shared vocabulary across functions
- Facilitating joint risk assessment sessions
- Aligning on model validation milestones
- Managing expectations around AI capabilities
- Creating feedback loops between QA and data science
- Documenting assumptions and limitations
- Establishing escalation paths for compliance issues
- Co-developing playbooks for incident response
- Measuring cross-functional collaboration
- Case study: aligning teams on an AI-based formulation tool
- Defining risk tiers for AI applications
- Mapping AI use cases to patient impact
- Using risk matrices for prioritization
- Resource allocation based on risk level
- Tiered validation approaches
- Proportionality in documentation requirements
- Dynamic risk reassessment over time
- Handling low-risk vs high-risk AI tools
- Risk communication to senior management
- Integrating AI risk into enterprise risk management
- Updating risk assessments post-deployment
- Case study: risk-based oversight of AI in lab equipment
- Shifting compliance left in project timelines
- Requirements gathering with QA involvement
- Designing for auditability from day one
- Incorporating ALCOA+ into data pipelines
- Building validation artifacts alongside code
- Early engagement with regulatory strategy
- Design reviews with compliance participation
- Ensuring model interpretability by design
- Documenting design decisions systematically
- Planning for scalability and maintenance
- Balancing innovation with compliance needs
- Case study: compliance-by-design in an AI-driven discovery platform
- Assessing vendor AI compliance maturity
- Contractual requirements for AI deliverables
- Evaluating transparency of black-box models
- Managing access to vendor-hosted AI systems
- Ensuring data protection in cloud-based AI
- Validating vendor-provided model documentation
- Audit rights and inspection clauses
- Handling vendor model updates
- Defining service level agreements for AI performance
- Managing exit strategies from vendor platforms
- Due diligence for AI acquisition
- Case study: onboarding a third-party AI for clinical data abstraction
- Defining model performance thresholds
- Monitoring for data and concept drift
- Alerting mechanisms for model degradation
- Root cause analysis for AI failures
- Escalation procedures for compliance incidents
- Documentation of model incidents
- Corrective and preventive actions (CAPA) integration
- Revalidation after incident resolution
- Communication plans for stakeholders
- Lessons learned from AI incidents
- Proactive model health checks
- Case study: responding to unexpected bias in an AI triage tool
- Tracking emerging AI technologies in pharma
- Updating internal policies as standards evolve
- Training teams on new compliance requirements
- Maintaining awareness of regulatory updates
- Building internal AI governance committees
- Knowledge sharing across departments
- Succession planning for AI compliance roles
- Benchmarking against industry peers
- Investing in continuous improvement
- Scaling compliance frameworks organization-wide
- Anticipating next-generation AI challenges
- Creating a roadmap for long-term AI compliance readiness
How this maps to your situation
- A compliance officer evaluating an AI tool for toxicology screening
- A QA lead preparing for an inspection of an AI-powered clinical data system
- A regulatory affairs manager building a submission package involving AI
- A data governance lead designing controls for AI model pipelines
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 4 hours per module, designed for flexible engagement around professional commitments.
How this compares to the alternatives
Unlike generic AI ethics courses or high-level webinars, this program delivers pharma-specific, implementation-grade knowledge with actionable templates and a real-world focus on GxP environments.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.